SCHEMBL11953286

SCHEMBL11953286

CC(C)(C)OC(=O)NC12CCCC(N)(CC1)C2

nearest known ligand 0.35

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
GAA P10253 1/20 0.33
DPP8 Q6V1X1 2/20 0.32
DPP9 Q86TI2 2/20 0.32
BTK Q06187 1/20 0.31
CTSL P07711 1/20 0.30
DGAT1 O75907 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22346156 0.94 MEN1 (0.39) MEN1MAPK1KMT2AGAADPP8
SCHEMBL20974036 0.87 MEN1 (0.39) MEN1MAPK1KMT2AGAADPP8
SCHEMBL20575845 0.84 MEN1 (0.41) MEN1MAPK1KMT2AGAADPP8
Hydrochloric Acid SCHEMBL30216284 0.82 MEN1 (0.40) MEN1MAPK1KMT2AGAADPP8
SCHEMBL20243118 0.82 MEN1 (0.41) MEN1MAPK1KMT2AGAADPP8
Hydrochloric Acid SCHEMBL28898542 0.80 MEN1 (0.41) MEN1MAPK1KMT2AGAADPP8
SCHEMBL21114477 0.79 MEN1 (0.40) MEN1MAPK1KMT2AGAADPP8
SCHEMBL18216705 0.78 BTK (0.35) MEN1MAPK1KMT2ADPP8DPP9
SCHEMBL16244297 0.77 MEN1 (0.34) MEN1MAPK1KMT2ADPP8DPP9
SCHEMBL16244106 0.77 MEN1 (0.34) MEN1MAPK1KMT2ADPP8DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170217950-A1 Bicyclo[3.2.1]Octyl Amide Derivatives and Uses of Same H. LUNDBECK A/S (DK) 2017-08-03 US disclosed
EP-2654422-B1 Bicyclo[3.2.1]octyl amide derivatives as allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5 or mGluR5) for the treatment of central nervous system (CNS) disorders H LUNDBECK AS (DK) 2017-08-02 EP disclosed
US-9656975-B2 Bicyclo[3.2.1]octyl amide derivatives and uses of same H. LUNDBECK A/S (DK) 2017-05-23 US disclosed
US-20150057289-A1 BICYCLO[3.2.1.]OCTYL AMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2015-02-26 US disclosed
US-8921370-B2 Bicyclo[3.2.1]octyl amide derivatives and uses of same H. LUNDBECK A/S (DK) 2014-12-30 US disclosed
US-20120190686-A1 BICYCLO[3.2.1]OCTYL AMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170217950-A1 Bicyclo[3.2.1]Octyl Amide Derivatives and Uses of Same SLC10A1, CLIC1, ABCB11 MEN1 1887/4885MAPK1 1042/4885KMT2A 2042/4885
US-20150057289-A1 BICYCLO[3.2.1.]OCTYL AMIDE DERIVATIVES AND USES OF SAME SLC10A1, CLIC1, ABCB11 MEN1 1833/4885MAPK1 1055/4885KMT2A 2342/4885
US-20120190686-A1 BICYCLO[3.2.1]OCTYL AMIDE DERIVATIVES AND USES OF SAME SLC10A1, CLIC1, ABCB11 MEN1 1887/4885MAPK1 1042/4885KMT2A 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.